Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study [Phase 2]
Phase 2 clinical trial evaluating geriatric assessment-guided interventions to accelerate functional recovery after CAR-T therapy in patient…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
The document announces a new clinical trial called HALO-SCT, assessing high-altitude observation in stem cell transplantation. It is current…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial [Phase 3]
Adaptive Phase 3 trial assessing optimized COVID-19 vaccination schedules for immunocompromised individuals, including patients with HIV and…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Multiple Myeloma Prognostic Indices
A completed clinical trial update examining prognostic indices for multiple myeloma to improve risk stratification in hematologic diseases.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma [NA]
ClinicalTrials.gov update on a study evaluating the feasibility and effects of exercise in patients with multiple myeloma; the trial status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating autologous stem cell transplant (ASCT) in combination with the CAR-T therapy C-…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating CT0596 in relapsed/refractory multiple myeloma and relapsed/refractory plasma cell leukemia is cu…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Limited-duration Teclistamab [Phase 2]
A Phase 2 trial evaluating a limited-duration dosing regimen of teclistamab for multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
A registry study tracking immune-related adverse events in cancer patients receiving immunotherapy. The study is not yet recruiting and is s…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a combination of elotuzumab, daratumumab, iberdomide, and dexamethasone in relapsed multiple myelom…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Iceland Screens, Treats or Prevents Multiple Myeloma [NA]
The Iceland iStopMM trial (NCT03327597) investigates screening, treatment, or prevention strategies to reduce progression from Monoclonal Ga…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating a BCMA/GPRC5D-targeted CAR-T therapy for refractory multiple myeloma. The study is not yet recruiting…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies [EARLY_Phase 1]
An early-phase trial evaluating Darzalex Faspro (daratumumab and hyaluronidase-fihj) given before desensitization and allogeneic stem cell t…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment [NA]
A clinical study is evaluating the safety and effectiveness of BCMA-GPRC5D CAR-T in relapsed/refractory multiple myeloma after third-line or…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for Isa-Rd (isatuximab plus lenalidomide-dexamethasone) in frail and/or very elderly patients with newly diagn…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Biomarker for Infection Risk in CLL and MM
This update describes a biomarker study to assess infection risk in patients with multiple myeloma and chronic lymphocytic leukemia. The tri…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
This clinical trial aims to build a research infrastructure to understand and address disparities in outcomes for multiple myeloma.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma [NA]
This document reports a clinical trial update examining how apixaban affects thrombin generation in patients with de novo multiple myeloma.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Precision Medicine Study
A precision medicine clinical trial sponsored by Icahn School of Medicine at Mount Sinai is currently recruiting for multiple myeloma.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating self-administered subcutaneous daratumumab for relapsed multiple mye…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. [NA]
This clinical trial update outlines a study evaluating whether an early warning system affects prognosis for patients with hematological mal…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Single-arm Single-center Trial of Bridging GPRC5D/CD3 Bispecific Antibody Treatment With BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
This entry describes an early-phase, single-arm, single-center trial evaluating bridging GPRC5D/CD3 bispecific antibody treatment followed b…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma [Phase 2]
Phase II clinical trial evaluating QLS32015 in combination therapy for relapsed or refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia [NA]
This ClinicalTrials.gov entry updates a study that uses high-throughput drug sensitivity and genomics to guide individualized treatment for …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating external beam radiation therapy in combination with talquetamab for the treatment of multiple myelo…